Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortization of Deferred ChargesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in ReceivablesChange in ReceivablesChange in TaxesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

OptimizeRx (OPRX) Non-cash Items (2018 - 2024)

OptimizeRx recorded quarterly Non-cash Items of $813397.0 in Q4 2024, down 80.23% quarter-over-quarter from $4.1 million in Q3 2024, and down 22.24% year-over-year from $1.0 million in Q1 2024.

OptimizeRx's Non-cash Items history runs 7 years deep, the most recent figure standing at $813397.0 for Q4 2024.

  • In Q4 2024, Non-cash Items fell 22.24% year-over-year to $813397.0; the TTM figure through Dec 2024 stood at $813397.0 (down 22.24% YoY), while the FY2024 annual figure was $813397.0, up 3197.38% from the prior year.
  • Non-cash Items came in at $813397.0 for Q4 2024 at OptimizeRx, down from $4.1 million in the prior quarter.
  • In the past five years, Non-cash Items ranged from a high of $4.1 million in Q3 2024 to a low of $26410.0 in Q1 2021.
  • A 5-year average of $1.0 million and a median of $652698.5 in 2024 frame the typical range for Non-cash Items.
  • Across the five-year window, Non-cash Items sank 95.81% in 2020 and surged 566.62% in 2023, its largest moves.
  • OptimizeRx's Non-cash Items stood at $1.5 million in 2020, then sank by 94.93% to $78334.0 in 2021, then surged by 100.31% to $156910.0 in 2022, then soared by 566.62% to $1.0 million in 2023, then slipped by 22.24% to $813397.0 in 2024.
  • According to Business Quant data, Non-cash Items over the past three periods registered $813397.0, $4.1 million, and $492000.0 for Q4 2024, Q3 2024, and Q1 2024 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Veeva Systems 30.85 Bn 24.28 Bn 622.47 Mn
2 BrightSpring Health Services 12.29 Bn 11.41 Bn 482.22 Mn
3 Healthequity 7.80 Bn 7.48 Bn 256.31 Mn
4 Hinge Health 4.82 Bn 4.51 Bn 154.23 Mn
5 Doximity 4.21 Bn 3.46 Bn 125.97 Mn
6 Waystar Holding 4.18 Bn 4.03 Bn 268.04 Mn
7 10x Genomics 3.78 Bn 3.24 Bn 106.18 Mn
8 Privia Health 2.65 Bn 2.28 Bn 595.71 Mn
9 Omnicell 1.95 Bn 1.78 Bn 140.36 Mn
10 OptimizeRx 101.31 Mn 81.14 Mn 15.12 Mn

Historic Data

Download Data 🔒
DateValue
Dec 31, 2024 813,397.00
Dec 31, 2024 813,397.00
Sep 30, 2024 4.12 Mn
Sep 30, 2024 4.12 Mn
Mar 31, 2024 492,000.00
Mar 31, 2024 492,000.00
Dec 31, 2023 1.05 Mn
Dec 31, 2023 1.05 Mn
Dec 31, 2022 156,910.00
Dec 31, 2022 156,910.00
Sep 30, 2021 78,334.00
Sep 30, 2021 78,334.00
Mar 31, 2021 26,410.00
Mar 31, 2021 26,410.00
Dec 31, 2020 1.55 Mn
Dec 31, 2020 1.55 Mn
Dec 31, 2019 36.86 Mn
Dec 31, 2019 36.86 Mn
Sep 30, 2019 1.46 Mn
Sep 30, 2019 1.46 Mn
Jun 30, 2019 16.33 Mn
Jun 30, 2019 16.33 Mn
Mar 31, 2019 1.56 Mn
Mar 31, 2019 1.56 Mn
Dec 31, 2018 7.93 Mn
Dec 31, 2018 7.93 Mn